DMRA
Damora Therapeutics, Inc.
$27.53
-2.47 (-8.23%)
At close · Jul 8
Market Cap
$1.69B
Shares
61,553,194
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding DMRA
28 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 1,758,674 | $52,021,577 | 0.06% | Long | 2026-02-28 | |
| Fidelity Small Cap Growth Fund | — | 834,040 | $21,401,466 | 0.25% | Long | 2026-04-30 | |
| Fidelity Growth Company K6 Fund | — | 521,922 | $15,438,453 | 0.07% | Long | 2026-02-28 | |
| Select Health Care Portfolio | — | 500,000 | $14,790,000 | 0.24% | Long | 2026-02-28 | |
| Select Biotechnology Portfolio | — | 454,559 | $13,445,855 | 0.25% | Long | 2026-02-28 | |
| Fidelity Series Growth Company Fund | — | 434,739 | $12,859,580 | 0.06% | Long | 2026-02-28 | |
| Fidelity Small Cap Growth K6 Fund | — | 410,184 | $10,525,321 | 0.25% | Long | 2026-04-30 | |
| Fidelity Stock Selector Small Cap Fund | — | 403,200 | $10,346,112 | 0.15% | Long | 2026-04-30 | |
| Fidelity Series Small Cap Opportunities Fund | — | 308,400 | $7,913,544 | 0.16% | Long | 2026-04-30 | |
| Fidelity Advisor Biotechnology Fund | — | 298,142 | $7,650,324 | 0.40% | Long | 2026-04-30 | |
| Fidelity Advisor Health Care Fund | — | 280,000 | $7,184,800 | 0.25% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 201,735 | $5,224,937 | 0.01% | Long | 2026-03-31 | |
| VIP Health Care Portfolio | — | 118,000 | $3,056,200 | 0.30% | Long | 2026-03-31 | |
| VIP Contrafund Portfolio | — | 105,500 | $2,732,450 | 0.01% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 82,575 | $2,442,569 | 0.01% | Long | 2026-02-28 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 93,797 | $2,429,342 | 0.03% | Long | 2026-03-31 | |
| Fidelity Fundamental Small-Mid Cap ETF | — | 36,352 | $932,792 | 0.07% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 29,516 | $873,083 | 0.00% | Long | 2026-02-28 | |
| Fidelity Series Total Market Index Fund | — | 23,248 | $687,676 | 0.00% | Long | 2026-02-28 | |
| Fidelity Advisor New Insights Fund | — | 23,800 | $616,420 | 0.00% | Long | 2026-03-31 | |
| Fidelity Series Opportunistic Insights Fund | — | 12,800 | $331,520 | 0.00% | Long | 2026-03-31 | |
| Schwab Total Stock Market Index Fund | — | 12,500 | $320,750 | 0.00% | Long | 2026-04-30 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 5,472 | $140,412 | 0.03% | Long | 2026-04-30 | |
| T. Rowe Price Extended Equity Market Index Fund | — | 4,323 | $111,966 | 0.01% | Long | 2026-03-31 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 1,693 | $43,442 | 0.02% | Long | 2026-04-30 | |
| Hypatia Women CEO ETF | — | 639 | $16,397 | 0.19% | Long | 2026-04-30 | |
| PROFUND VP BIOTECHNOLOGY | — | 522 | $13,520 | 0.03% | Long | 2026-03-31 | |
| State Street Balanced Index Fund | — | 167 | $4,325 | 0.00% | Long | 2026-03-31 |
Showing 1–28 of 28 positions